Effect of Combination Treatment with GLP-1 Receptor Agonist and SGLT-2 Inhibitors on Incidence of Cardiovascular and Serious Renal Events . mfm. 2024;35(6). Accessed November 17, 2025. https://medicalforummonthly.com/index.php/mfm/article/view/4697